Upcoming Courses

Psychopharmacology, 2014: A Master Class

Ross J. Baldessarini, MD, DSc (hon), Barbara Coffey, MD, MS , Nassir Ghaemi, MD, MPH, Jeffrey Lieberman, MD, Lawrence E. Lifson, MD Charles Nemeroff, MD, PhD,Carl Salzman, MD, Alan F. Schatzberg, MD, David Sheehan, MD, MBA, Daniel Weinberger, MD, Roger Weiss, MD, John Winkelman, MD, PhD , Kimberly Yonkers, MD

April 25, 2014 – April 26, 2014 | Boston, MA | The Fairmont Copley Plaza Hotel More Information

This unique two-day course is designed for the experienced clinician. The objectives of this course are to provide, in a lecture and question and answer format, a review of the mechanisms and clinical applications of psychotropic drug treatments with particular emphasis on difficult-to-treat patients. Course participants will be expected to have had clinical experience, familiarity with the neurobiological and genetic contributions to psychiatric illnesses as well as an understanding of the basic therapeutic mechanisms of psychotropic medications. There will be considerable opportunity for interaction with the presenters.

This course is designed so that participants will be able to:
  • Evaluate current effects of psychotropic drug treatment on neurotransmitters, receptors and genes;
  • Analyze the genetic mechanisms and current treatment as well as emerging treatments of schizophrenia, bipolar, depression, anxiety and personality disorders;
  • Distinguish between normal function and women’s mental health issues, as well as the treatment of PMS, perinatal and postpartum disorders;
  • Determine the multiple functions of sleep and dreaming as well as the appropriate treatment of sleep disorders and substance abuse disorders; and
  • Assess the latest advances in child, adolescent and geriatric psychopharmacology and incorporate new [A1] psychological treatment approaches in these age groups.

Additional Information

Fees

Warning: Invalid argument supplied for foreach() in /nfs/c10/h13/mnt/150145/domains/continuingeducationprogram.org/html/wp-content/themes/bidmc/single-courses.php on line 110

Beth Israel Deaconess Department of Psychiatry Foundation, Inc./Contact Hours: 12.50

Accreditation:

Physicians: Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Harvard Medical School designates this live activity for a maximum of 12.50AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Psychologists: The Continuing Education Program at Beth Israel Deaconess Medical Center is approved by the American Psychological Association to offer continuing education for psychologists. The Continuing Education Program at Beth Israel Deaconess Medical Center maintains responsibility for the program.

Nurses: Application has been made to the Massachusetts Association for Registered Nurses (MARN) for approval to award contact hours. MARN is accredited as an approver of continuing education by the American Nurses Credentialing Center’s Commision on Accreditation

Faculty

Ross J. Baldessarini, MD, DSc (hon) 
Professor of Psychiatry and in Neuroscience, Harvard Medical School; Director of the Psychopharmacology Program and International Consortium for Bipolar Disorder Research at McLean Hospital; Author of nearly 2100 scientific publications and several books, including Chemotherapy in Psychiatry and for several decades, the chapters on psychopharmacology in the standard American textbook of pharmacology, Goodman and Gilman’s The Pharmacological Basis of Therapeutics; Member of editorial boards of several leading clinical and neuroscience journals.

Barbara Coffey, MD, MS 
Chief, Tics and Tourette’s Clinical and Research Program, Icahn School of Medicine at Mount Sinai; Professor, Department of Psychiatry and Research Psychiatrist, Nathan Kline Institute for Psychiatric Research; Former Director of the Tics and Tourette’s Clinics at McLean and Massachusetts General Hospitals and NYU Child Study Center, and former Director of Pediatric Psychopharmacology at McLean Hospital; Associate Editor,Advanced Pediatric Psychopharmacology, Journal of Child andAdolescent Psychopharmacology.

Nassir Ghaemi, MD, MPH 
Lecturer on Psychiatry, Harvard Medical School; Professor of Psychiatry, Tufts University School of Medicine; Director, Mood Disorders, Tufts Medical Center; Author, A First-Rate Madness: Uncovering the Links Between Mental Illness and Leadershipand A Clinician’s Guide to Statistics and Epidemiology in Mental Health and The Rise and Fall of Biopsychosocial Model and The Concepts of Psychiatry: A Pluralistic Approach to the Mind and Mental Illness, and Mood Disorders: A Practical Guide and co-author, Bipolar Depression.

Jeffrey Lieberman, MD 
Lawrence C. Kolb Professor and Chairman, Department of Psychiatry, Columbia University College of Physicians and Surgeons; President, American Psychiatric Association, Director, New York State Psychiatric Institute, Psychiatrist-in-Chief, Columbia University Medical Center of the NewYork-Presbyterian Hospital; author of over 450 scientific articles; author or editor of eight books.

Charles Nemeroff, MD, PhD
Leonard M. Miller Professor and Chairman, Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine; past President of the American College of Psychiatrists, International Society of Psychoneuroendocrinology and the American College of Neuropsychopharmacology; member of the Institute of Medicine; author of over 1,000 scientific articles and book chapters, co-editor, Textbook of Psychopharmacology.

Alan F. Schatzberg, MD
Kenneth Norris Jr. Professor and Chairman, Department of Psychiatry and Behavioral Sciences, Emeritus, Stanford University; past President, American Psychiatric Association; editorial board of many journals; author of over 600 publications; co-author, Manual of Clinical Psychopharmacology; Co-editor ofTextbook of Psychopharmacology.

David Sheehan, MD, MBA 
Distinguished University Health Professor at the University of South Florida College of Medicine, Director of the Depression and Anxiety Disorder Research Institute at the University of South Florida College of Medicine; past consultant to the World Health Organization and the U.S. Federal Drug Administration; Author of over 500 abstracts and 250 publications; Editorial board of 8 publications; author, The Anxiety Disease.

Daniel Weinberger, MD 
Director of the Genes, Cognition and Psychosis Program of the Intramural Research Program, National Institute of Mental Health, National Institutes of Health; past president of the Society of Biological Psychiatry and the American College of Neuropsychopharmacology; member, Institute of Medicine of the National Academy of Sciences; Editorial boards of sixteen scientific journals; author of over four hundred scientific articles; author or editor of six books.

Roger Weiss, MD
Professor of Psychiatry, Harvard Medical School and Chief of the Division of Alcohol and Drug Abuse at McLean Hospital. Author, over 300 scientific publications including, Integrated Group Therapy for Bipolar Disorder and Substance Abuse; Editorial board of many journals including American Journal of Drug and Alcohol Abuse, Journal of Clinical Psychiatry, and the American Journal on Addictions.

John Winkelman, MD, PhD 
Associate Professor of Psychiatry, Harvard Medical School, and Medical Director of the Sleep Health Center of Brigham and Women’s Hospital; Past Chair of the Nosology committee of the American Academy of Sleep Medicine; Chair, Associate Editor forSleep; editorial boards of Sleep Medicine, CNS Drugs and the International Journal of Sleep Disorders; Editor, Foundations of Psychiatric Sleep Medicine.

Kimberly Yonkers, MD 
Professor in the Department of Psychiatry and Obstetrics, Gynecology and Reproductive Sciences at the Yale School of Medicine; past President of the North American Society of Psychosocial Ob-Gyn; Author, Depression in Women, and coeditor of Mood Disorders in Women and Management of Psychiatric Disorders in Pregnancy.